Energin

Energin, licence 80068465: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder: NHT Global Inc.
NPN or DIN-HM: 80068465
Status: Inactive licence
Licence date: 12 April 2016
Revision date: 4 April 2018
Form: Capsule
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Paeonia lactiflora Source : Racine Extract : Matériel brut sec Extraction ratio : 12.0:1.0 Dry plant equivalent : 300.0 mg	25.0 mg	Not calculated
Paullinia cupana Source : Paullinia cupana - Graine Extract : Matériel brut sec Extraction ratio : 3.0:1.0 Dry plant equivalent : 405.0 mg Potency : 12.0 % Caffeine	135.0 mg	Not calculated
Paecilomyces hepiali Source : Cultured mycelia Potency : 7.0 % Mannitol	70.0 mg	Not calculated
Crataegus monogyna Source : Crataegus monogyna- Fruit Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 100.0 mg	25.0 mg	Not calculated
Ilex paraguariensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 300.0 mg Potency : 5.0 % Caffeine	75.0 mg	Not calculated
Schisandra sphenanthera Source : Fruit Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 20.0 mg	5.0 mg	Not calculated
Petroselinum crispum Source : Sommité Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 100.0 mg	25.0 mg	Not calculated
Camellia sinensis Source : Feuille Potency : 35.0 % Catechins	10.0 mg	Not calculated
Camellia sinensis Source : Feuille Potency : 15.0 % Epigallocatechin 3-gallate	Not specified	Not calculated
Camellia sinensis Source : Feuille Potency : 10.0 % Caffeine	Not specified	Not calculated
1,3,7-triméthylxanthine Source : Paullinia cupana - Graine	17.7 mg	Not calculated
1,3,7-triméthylxanthine Source : Ilex paraguariensis - feuille	17.7 mg	Not calculated
Niacine Source : Niacine	4.0 mg	Not calculated
Panax ginseng Source : Panax ginseng - racine Extract : Matériel brut sec Extraction ratio : 45.0:1.0 Dry plant equivalent : 9.0 g Potency : 20.0 % Total ginsenosides	200.0 mg	Not calculated
Astragalus membranaceus Source : Astragalus membranaceus - racine Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 100.0 mg	10.0 mg	Not calculated

Non-medicinal ingredients

Gélatine, Dioxyde de silicium

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	1.0 Capsule	1.0 Jour(s)

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps the body to metabolize carbohydrates, proteins and fats. Helps normal growth and development. Source of fungal polysaccharides with immunomodulating properties. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. (Used in Herbal Medicine as) supportive therapy for the promotion of healthy glucose levels. (Used in Herbal Medicine to) help(s) support cognitive function and/or reduce mental fatigue (in cases of mental stress). Used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80068465

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 4 April 2018 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2018. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.